Company Filing History:
Years Active: 2019
Title: Phoebe Lam: Innovator in Radiopharmaceuticals
Introduction
Phoebe Lam is a distinguished inventor based in Zurich, Switzerland. She has made significant contributions to the field of radiopharmaceuticals, particularly in the synthesis of F-labelled folates. Her innovative work is aimed at improving cancer diagnosis and treatment.
Latest Patents
Phoebe Lam holds a patent for a novel method of synthesizing F-folate radiopharmaceuticals. This invention involves the attachment of fluorine-18 to a pteroate or folate through direct radiolabeling with [F]fluoride. The resulting F-folate radiopharmaceuticals are designed for use in the diagnosis and monitoring of cancer therapy, as well as the treatment of inflammatory and autoimmune diseases.
Career Highlights
Phoebe is currently employed at Merck & Cie, where she continues to advance her research in the field of pharmaceuticals. Her work has garnered attention for its potential impact on medical diagnostics and therapeutic strategies.
Collaborations
Throughout her career, Phoebe has collaborated with notable colleagues, including Simon Mensah Ametamey and Rudolf Moser. These partnerships have contributed to the success and development of her innovative projects.
Conclusion
Phoebe Lam is a pioneering inventor whose work in radiopharmaceuticals is paving the way for advancements in cancer diagnosis and treatment. Her contributions are vital to the ongoing evolution of medical science.